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doi:10.1016/j.jfma.2011.12.003Background/Purpose: Stargardt’s disease is the most common form of juvenile macular
dystrophy. The purpose of this study is to report the clinical characteristics, visual function,
and retinal tomography of patients diagnosed with Stargardt’s disease in Taiwan.
Methods: Retrospective case series; data collected include results of complete ophthalmic
examinations: best-corrected visual acuity (BCVA), slit-lamp biomicroscopy, indirect ophthal-
moscopy, fundus photography, fluorescein angiography, color sense discrimination test, elec-
troculography (EOG), electroretinography (ERG), dark adaptation, visual field test, and
optical coherence tomography (OCT) examinations focused on the macular area.
Results: Twenty patients were enrolled in this study. The mean age of the patients was 32.1
years. The mean logMAR-converted visual acuity of all patients was 0.96. Maculopathy with
or without flecks was evident in all patients. Fluorescein angiography revealed hyperfluores-
cence in the macula of all cases. Varying degrees of color sense discrimination dysfunction
were noted. Electrophysiologic studies showed subnormal to abnormal responses in most
patients. Decreased foveal thickness was evident on OCT and foveal thickness was inversely
associated with logMAR visual acuity. Also, logMAR visual acuity was associated with total error
scores on the color sense discrimination test and the Arden ratio of EOG. The Arden ratio of
EOG correlated with the thickness of the outer ring of the macula.
Conclusion: Typical clinical presentations of Stargardt’s disease were demonstrated in our
case series. OCT findings showed a correlation between foveal thickness and visual acuity,t of Ophthalmology, National Taiwan University Hospital, College of Medicine, National Taiwan
th Road, Taipei 100, Taiwan.
.tw (T.-C. Ho).
ight ª 2012, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.
80 J.-P. Sun et al.making OCT a useful predictor for other visual function tests. Our results indicate that OCT is
helpful in the evaluation of visual acuity and the progression of maculopathy in patients with
Stargardt’s disease.
Copyright ª 2012, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.Introduction
Stargardt’s disease (STGD), first described by Karl Star-
gardt1 in 1909, is the most common form of juvenile
macular dystrophy and a common cause of loss of central
vision in adults younger than 50 years old.2 Stargardt’s
disease typically affects young, healthy individuals in the
first or second decade of life. The typical appearance of the
fundus in STGD is characterized by progressive and
symmetrical atrophy of the macula in young individuals,
which is eventually surrounded by irregular, white-yellow
deep flecks or spots.1,2 Most patients have inherited STGD
as an autosomal recessive trait, but in some families it has
been reported as an autosomal dominant trait.2e5 STGD
commonly is caused by mutations of the ABCA4 gene,
located on the short arm of chromosome 1.6 Less frequently
cited are the dominant genes STGD4, ELOVL4, and the RDS/
peripherin gene.5,7
In 1962, Francesschetti8 introduced the term fundus
flavimaculatus to describe the presence of scattered pis-
ciform, or round, whitish to yellowish flecks at the level of
the retinal pigment epithelium (RPE) throughout the
posterior pole that may also extend to the mid-peripheral
retina. Krill and Deutman9 pointed out that some patients
reported by Karl Stargardt1 also had flecks in the posterior
pole and peripheral retina. Today, STGD and fundus flavi-
maculatus are accepted as representing the same disorder
affecting the photoreceptor layer and the RPE.2,10,11
The clinical presentation of STGD includes progressive
loss of central vision, presence of an atrophic lesion at the
macula, and eventually, a surrounding ring of white-yellow
flecks that may extend into the midperipheral retina. The
diagnosis of STGD is based on family history, fundus
appearance, fluorescein angiography, and visual function
examinations including color vision, electroculography
(EOG), electroretinography (ERG), dark adaptation, and
visual fields. A genetic test is not performed routinely for
this disease at present.
Optical coherence tomography (OCT) is a noninvasive
and well-established method of detecting retinal archi-
tecture. It also has been widely used to diagnose and
monitor a variety of retinal and optic disc disorders. Some
studies describe the use of conventional OCT or ultrahigh-
resolution OCT in STGD or macular dystrophy patients.10e14
Querques et al12 found visual acuity impairment signifi-
cantly correlated to the degree of foveal thinning in
patients with STGD. Berisha et al13 used OCT to find a strong
correlation between foveal thickness and visual function in
patients with STGD. They found that reduced foveomacular
thickness in the macular area may be useful in diagnosing
STGD, even in patients with early and mild presentation of
this disease.
In the present study, we investigate the clinical char-
acteristics and visual function of patients with STGD, usingOCT to study the retinal tomography. We also analyze the
relationship between retinal tomography and visual func-
tion tests, including best-corrected visual acuity (BCVA),
EOG, and color sense discrimination tests.Materials and methods
This study is a retrospective, observational case series
study. We enrolled 20 patients diagnosed with STGD in the
Department of Ophthalmology, National Taiwan University
Hospital, Taipei, from January 2009 to December 2010. All
patients had received complete ophthalmic examinations
including BCVA, slit-lamp biomicroscopy, indirect ophthal-
moscopy, fundus photography, fluorescein angiography,
a color sense discrimination test, EOG, ERG, dark adapta-
tion, a visual field test, and OCT examinations of the
macular area.
Patients at different stages of STGD were included in the
study. Exclusion criteria included a history of ocular
trauma, intraocular laser treatment, intraocular surgery,
presence of any other retinal disease, glaucoma, optic
neuropathy, high degree of myopia with refraction greater
than -8.0D, or hyperopia with refraction greater than
þ5.0D. Patients with systemic diseases that may affect the
retina (e.g., diabetes or hypertension) also were excluded.
BCVA was examined using a Snellen chart with a cali-
brated luminance. According to the equation that Snellen
visual acuity equals 1/MAR (MAR Z minimal angle of reso-
lution), Snellen visual acuity was converted to logMAR for
statistical analysis.
The color sense discrimination test was evaluated with
the Farnsworth-Munsell 100-Hue test. In this test, a patient
arranges four trays of colored caps in order by hue. The
better the patient’s color sense discrimination, the closer
the arrangement matches the predetermined sequence for
each tray. The result was scored using the Farnsworth-
Munsell 100-Hue Test Scoring Software and displayed in
polar format. The total error score was recorded for
analysis.15,16
Electroculography (EOG) was used to evaluate the
function of the outer retina and RPE. EOG is performed with
a dilated pupil, starting with 15 minutes in the dark, then
15 minutes in the light. During dark adaptation, the resting
potential decreases gradually and reaches a minimum, the
so-called dark trough. After the light is turned on, the
resting potential increases to maximum, or light peak. The
Arden ratio, calculated as the ratio of light peak voltage to
dark trough voltage, was recorded for analysis.
Electroretinography (ERG) was used to assess cone cell
and rod cell function. A Ganzfeld bow with standardized
intensity of light was used. ERG was performed with the
pupils maximally dilated, and scotopic and photopic ERG
recordings were recorded.
Table 1 Characteristics and visual acuity of patients.
Patient Age Gender Lesion Visual acuityb
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Weekers adaptomoter, testing a single point 15 degrees
from fixation. Following pupillary dilatation, the patient is
dark adapted for a few minutes and then exposed to
a bright, preadaptating light for 6 to 8 minutes. Dark
adaptation is then started and retinal sensitivity is tested
for 40 minutes. Results were recorded, and the final
threshold for rod adaptation was measured.
A visual field test was performed using Goldmann kinetic
perimetry with different sizes and illuminations of testing
spots. The location and pattern of visual field defect were
recorded.
Retinal tomography was evaluated with commercial OCT
units (OCT3, Carl Zeiss Meditec, Inc., Dublin, CA) under
pupillary dilatation by an experienced examiner. Retinal
thickness was calculated using OCT retinal mapping soft-
ware, which measured the thickness of nine macular
regions after six scans 6 mm long, centered on the patient’s
fixation point by means of an inner fixation target. The
result is expressed as a color map.17,18 The foveal area is
defined as the area within 1 mm of the fixation point, the
inner ring as the area 1e3 mm from the fovea, and the
outer ring as the area 3e6 mm around the fovea (Fig. 1).
Each ring was divided further into four quadrants. For
analysis, we defined the superior quadrant as the inner
superior area plus the outer superior area; similar defini-
tions held for the interior, nasal, and temporal quadrants
(Fig. 1).
We collected patients’ characteristics, results of visual
function tests, and retinal tomography, and then analyzed
the relationship between retinal tomography and visual
function tests. Data analysis was performed using Stata 8.2
software (Stata Corp, Collage Station, TX). A two-sided p
value <0.05 was considered statistically significant.
Continuous data were presented as mean þ standard
deviation (SD). Linear regression was used to identify
predictive factors indicating macular visual dysfunction.(years) sitesa OD OS
1 76 Male OU 20/50 20/125
2 48 Female OU 20/40 20/200
3 28 Male OU 20/200 20/400
4 53 Female OU 20/125 20/200Results
We enrolled 20 patients for analysis (40 eyes), seven males
and 13 females. The mean age was 32.1 years, with a rangeFigure 1 The Optical Coherence Tomography map. The
fovea is the central area at fixation, with a diameter of 1 mm.
The inner ring is the area with a diameter 1e3 mm, and the
outer ring is the area 3e6 mm.of 10 years old to 76 years old (SDZ 18.03 years) (Table 1).
The most common initial complaint, decreased central
visual acuity, was noted in 18 patients. The other two
patients complained of nyctalopia and metamorphopsia,
respectively. The age of onset in patients was as follows:
(1) five patients were noticed in the first decade of life; (2)
nine patients were noticed in the second decade; (3) three
were noticed in the third and fourth decades; (4) two
patients in the fifth decade; and (5) one patient in the sixth
decade. Autosomal recessive inheritance was indicated in
five patients: two patients were sisters, two patients had
a history of an affected sibling, and one had a history of
parental consanguinity. One patient gave a history
compatible with X-linked recessive transmission, but family
members were not examined.
The mean logMAR-converted visual acuity of all patients
was 0.96 (SD Z 0.35). The majority of patients had visual
acuity in the better eye between 20/40 and 20/400. Four
patients had visual acuity of 20/40 or better, three had
visual acuity between 20/50 and 20/80, and 13 had visual
acuity between 20/100 and 20/400. Two patients had
a marked asymmetry in vision, with visual acuity in the
better eye of 20/40 or better, and in the worse eye of 20/
200, despite a symmetrical fundus appearance (Table 1).
For assessing the visual acuity in subgroup analysis,
including age at examination, age at onset, interval
between age at onset and age at examination, and family
history, the visual acuity in the better-seeing eye at the
patient’s visit was used for evaluation. Assessing the
impairment of visual acuity within the age at examination
groups, 50% of the patients who were in the less-than-20
years old age group had visual acuity of 20/40 or better in
at least one eye compared with 9% within the 20-to-40 age
group and 20% in the more-than-40 age group (Table 2).5 12 Male OU 20/400 20/400
6 33 Female OU 20/400 20/400
7 26 Female OU 20/200 20/200
8 66 Female OU 20/80 20/200
9 23 Female OU 20/125 20/100
10 50 Female OU 20/100 20/100
11 25 Female OU 20/40 20/40
12 31 Female OU 20/125 20/125
13 25 Female OU 20/100 20/100
14 11 Male OU 20/400 20/400
15 34 Male OU 20/200 20/200
16 10 Male OU 20/25 20/200
17 22 Female OU 20/63 20/63
18 23 Female OU 20/200 20/125
19 14 Female OU 20/63 20/40
20 32 Male OU 20/200 20/125
a OU Z both eyes.
b OD Z right eye; OS Z left eye.
Table 2 Distribution of visual acuity with age at exami-
nation, age at onset, interval between age at onset and
examination, and family history of patients [number(%)].
20/40 or
better
20/50e20/
100
Worse than
20/100
Total
Age at examination, yr
<20 2(50) 0(0) 2(50) 4
20e40 1(9) 3(27) 7(64) 11
>40 1(20) 3(60) 1(20) 5
Age at onset, yr
<20 3(21) 3(21) 8(58) 14
20e40 1(34) 1(33) 1(33) 3
>40 0(0) 2(67) 1(33) 3
Interval between age at onset and examination, yr
<10 4(57) 1(14) 2(29) 7
10e20 0(0) 5(45) 6(55) 11
>20 0(0) 0(0) 2(100) 2
Family history
Yes 2(33) 1(17) 3(50) 6
No 2(14) 5(36) 7(50) 14
82 J.-P. Sun et al.We also examined the impairment of visual acuity within
the age at onset groups. Fifty-eight percent of the patients
who had age at onset of less than 20 years had visual acuity
that was worse than 20/100 in at least one eye, comparedFigure 2 Representative color fundus photography, fluorescein
Patient 16. (A) Color fundus photograph of the right eye, showing bu
eye hyperfluorescence pattern in the right eye. (C) OCT shows leswith 33% within the 20 to 40 age at onset group, and 33% in
the more than 40 age at onset group.
We assessed the impairment of visual acuity within the
groups according to the interval between age at onset and
age at examination. Fifty-seven percent of the patients
who had an interval less than 10 years had visual acuity of
20/40 or better in at least one eye, compared with 0% of
the patients having an interval between 10 to 20 years, and
0% at an interval of more than 20 years. Meanwhile, the
patients with an interval 10 years or less, 10 to 20 years,
and more than 20 years, respectively, having a visual acuity
of worse than 20/100, was 29%, 55%, and 100%, respec-
tively. We evaluated the impairment of visual acuity
according to the presence of family history of the patients.
Fifty percent of the patients who had a positive family
history had a visual acuity of worse than 20/100 in at least
one eye compared with 50% of the patients who had no
family history.
Macular disease was evident in all patients, appearing as
maculopathy without flecks (14 patients), maculopathy
with perifoveal flecks (5 patients), or maculopathy associ-
ated with diffuse posterior pole flecks (1 patient). The
flecks varied from white to yellowish-white and were
occasionally associated with pigmentary changes. Fundus
examination showed loss of foveal light reflex in all
patients. The macular hypopigmentation pattern, which
presumably represents atrophy of the RPE, was classified as
two types: (1) a bull’s-eye appearance, in which the normal
central RPE is surrounded by depigmentation due to RPE
atrophy (11 patients, Fig. 2); and (2) diffuse atrophicangiography, and optical coherence tomography (OCT) for
ll’s-eye appearance. (B) Fluorescein angiography reveals bull’s-
s affected foveal thickness than in more severe patients.
Stargart’s disease in Taiwan 83change, or beaten-bronze appearance (9 patients, Fig. 3).
No abnormality was found in the retinal vessels or optic disc
in our patients (Table 3). The morphology of the macular
change was symmetrical in all patients.
Fluorescein angiography revealed hyperfluorescence
due to RPE atrophy in the macula of all patients with two
types of hyperfluorescent pattern. Eleven patients had the
bull’s-eye pattern (Fig. 2) and nine patients had an oval-
shaped appearance (Fig. 3). Dark choroid was found in 14
patients (Table 3).
Color vision testing with Farnsworth-Munsell 100-Hue
test was performed in all patients. The mean total errors of
the Farnsworth-Munsell 100-Hue test was 245.9
(SD Z 169.1). The total error score of the Farnsworth-
Munsell 100-Hue test was significantly associated with
logMAR-converted visual acuity (p < 0.05). The results
showed color vision dysfunction in all patients. One patient
had an asymmetry in color vision, with normal color vision
in one eye and abnormal color vision in another eye (Patient
9) (Table 4).
EOG was performed in 19 patients and showed a mean
Arden ratio of 1.86 (SDZ 0.48). The criteria of Arden ratio
in this study was normal, >1.80; subnormal, 1.65-1.79; and
abnormal, <1.65. Results were normal in nine patients,
abnormal in seven patients, and mixed in three (a normal
response in one eye and an abnormal response in the other
eye). One patient (Patient 5) with abnormal EOG hadFigure 3 Representative color fundus photography, fluorescein
Patient 17. (A) Color fundus photography shows beaten-bronze ap
oval-shape hyperfluorescence pattern in the right eye. (C) OCT shodiffuse posterior pole flecks and two patients had peri-
foveal flecks. The Arden ratio was correlated with logMAR-
converted visual acuity (p Z 0.001).
ERG was performed in all patients and showed normal
scotopic and photopic responses in five patients. Two
patients had both abnormal scotopic and photopic
responses (Table 4). An ERG was performed in the seven
patients with abnormal EOG. Results were abnormal to
subnormal in five patients, while the other two patients had
a normal scotopic response and subnormal photopic
response (Table 4). The dark adaptation test was performed
in all patients and 14 showed a normal final threshold. The
final threshold was elevated in the other six patients (Table
4). The Goldmann perimeter showed that the central or
paracentral scotoma could be observed in nine patients,
especially those with poorer vision. Four patients had
generalized constriction (Table 4).
To analyze macular thickness as seen by retinal tomog-
raphy, we measured the thickness of the foveal area, the
inner ring, and the outer ring of all patients. The mean  SD
thickness of the foveal area, the inner ring, and the outer
ring were 130.30  35.55 mm, 205.68  18.07 mm, and
214.19  25.31 mm, respectively. The mean thickness of the
fovea was much thinner than for the other two areas.
Retinal tomography as shown by OCT revealed that the
thickest quadrant on average was the nasal quadrant, at
219.08  19.18 mm (mean  SD), followed by the superiorangiography, and optical coherence tomography (OCT) for
pearance in the right eye. (B) Fluorescein angiography reveals
ws markedly reduced foveal thickness.
Table 3 Results of fundus and fluorescein angiographic appearance.
Patient Foveal light
reflex
Macula hypopigmentation
pattern
Retina
vessels
Optic
disc
Macula hyperfluorescence
pattern
Choroid pattern
1 Disappeared Bull’s-eye appearance Normal Normal Bull’s-eye pattern Dark choroid
2 Disappeared Bull’s-eye appearance Normal Normal Bull’s-eye pattern Dark choroid
3 Disappeared Bull’s-eye appearance Normal Normal Bull’s-eye pattern Dark choroid
4 Disappeared Beaten-bronze appearance Normal Normal Oval-shape Dark choroid
5 Disappeared Beaten-bronze appearance Normal Normal Oval-shape Dark choroid
6 Disappeared Bull’s-eye appearance Normal Normal Bull’s-eye pattern Dark choroid
7 Disappeared Bull’s-eye appearance Normal Normal Bull’s-eye pattern No dark choroid
8 Disappeared Beaten-bronze appearance Normal Normal Oval-shape Dark choroid
9 Disappeared Bull’s-eye appearance Normal Normal Bull’s-eye pattern No dark choroid
10 Disappeared Bull’s-eye appearance Normal Normal Bull’s-eye pattern No dark choroid
11 Disappeared Bull’s-eye appearance Normal Normal Bull’s-eye pattern Dark choroid
12 Disappeared Beaten-bronze appearance Normal Normal Oval-shape Dark choroid
13 Disappeared Beaten-bronze appearance Normal Normal Oval-shape Dark choroid
14 Disappeared Bull’s-eye appearance Normal Normal Bull’s-eye pattern Dark choroid
15 Disappeared Beaten-bronze appearance Normal Normal Oval-shape No dark choroid
16 Disappeared Bull’s-eye appearance Normal Normal Bull’s-eye pattern No dark choroid
17 Disappeared Beaten-bronze appearance Normal Normal Oval-shape Dark choroid
18 Disappeared Beaten-bronze appearance Normal Normal Oval-shape Dark choroid
19 Disappeared Bull’s-eye appearance Normal Normal Bull’s-eye pattern Dark choroid
20 Disappeared Beaten-bronze appearance Normal Normal Oval-shape No dark choroid
Table 4 Results of visual function tests.
Patient ERGa EOGb (Arden
ratio)
Color vision
(100-Hue
test, total
error score)
Dark
adaptationc
(No. of Log
unit
elevation)
Visual field
Scotopic
response
Photopic
response
OD OS OD OS OD OS OD OS OD OS
1 2 2 2 2 2.35 2.57 339 437 1.2 1 Central scotoma
2 3 3 2 2 1.4 1.16 260 377 N N Central scotoma with
generalized constricted VF
3 1 1 2 2 1.27 1.50 192 216 N N No scotoma
4 1 1 1 1 1.85 1.96 516 720 N N Central scotoma
5 3 3 3 3 1.5 1.45 479 391 N N Central scotoma
6 2 2 2 2 1.52 1.48 208 232 0.8 0.8 Central scotoma
7 1 1 1 1 2.22 2.26 60 80 N N No scotoma
8 3 3 2 2 1.33 1.38 331 546 N N Paracentral scotoma
9 2 2 2 2 2.6 2.55 108 36 N N Generalized constricted VF
10 1 1 1 1 2.66 2.13 164 144 N N No scotoma
11 1 1 2 2 2.16 1.94 88 72 N N No scotoma
12 1 1 2 2 0.98 1.27 79 82 N N Central scotoma
13 2 2 1 1 1.37 1.82 108 105 N N No scotoma
14 3 3 3 3 1.85 1.55 507 483 0.6 1.4 Central scotoma
15 2 2 2 2 1.61 1.49 391 440 1.0 1.1 Paracentral scotoma
16 1 1 1 1 d d 157 273 N N Generalized constricted VF
17 1 1 1 1 2.08 2.58 272 181 N N Generalized constricted VF
18 2 2 1 1 1.85 2.18 152 148 1.7 2.6 No scotoma
19 1 2 1 2 1.89 1.77 113 114 N N No scotoma
20 2 2 2 2 2.3 2.8 80 156 1.9 1.8 No scotoma
a 1 Z normal; 2 Z subnormal; 3 Z abnormal; OD Z right eye; OS Z left eye.
b d Z not performed.
c N Z normal.
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Stargart’s disease in Taiwan 85quadrant (215.08  23.76 mm), the inferior quadrant
(209.43  18.74 mm), and finally, the temporal quadrant
(196.14  20.59 mm).
During the same period of time, we recruited 40 age-
matched patients as the controls who had undergone OCT
examination due to unilateral retinal diseases such as central
serous chorioretinopathy, branch retinal vein occlusion or
central retinal vein occlusion, idiopathic choroidal neo-
vascularization, and foveal atrophy. Macular thickness of the
unaffectedeyes detectedbyOCTwasusedas thecontrol data
in this study. The thickness of the foveal area, the inner ring,
and the outer ring in the controls were 250.41  13.69 mm,
318.0  11.94 mm, and 275.38  11.73 mm, respectively. The
thicknesses of the nasal quadrant, upper quadrant, temporal
quadrant, and inferior quadrant in controls were
311.76 13.61mm,300.40 10.01mm,284.16 9.02mm,and
290.48  12.17 mm, respectively. In comparison with the
macular thickness between patients with STDG and controls,
it is noted that the thicknessofeveryareamentionedabove in
patients with STGD was much less than those in the controls
(all p < 0.001).
Analyzing the correlation between visual functions (VA,
color vision, and EOG) and retinal tomography as shown by
OCT in patients with STGD, we found logMAR-converted VA
was significantly inversely correlated with foveal thickness
(p Z 0.047). The Arden ratio of EOG correlated well with
the thickness of the outer ring (pZ 0.026). The total error
score of the Farnsworth-Munsell 100-Hue Test was not
correlated with macular thickness (all p > 0.05).Discussion
The major symptom of STGD is the progressive deteriora-
tion of visual acuity and a final visual acuity of around 20/20
to 20/400.3,10,19 Previous cross-sectional studies demon-
strated that a range of 14% to 37% of STGD patients had 20/
40 or better visual acuity.3,19,20,21
Our study showed 20% of the patients had a visual acuity
of 20/40 or better. Our study further demonstrated that
most patients (10 or 50%) had a visual acuity worse than 20/
100, which is consistent with previous studies.19,20 Our
study demonstrated that patients with age at onset of less
than 20 years tend to have a visual acuity worse than 20/
100 at their visit. A previous study demonstrated that
patients with decreased visual acuity and a previous history
of normal vision, the age at onset usually was in the first
and second decades.3
Our study further showed that patients with an interval
between age at onset and examination of less than 10 years
tend to have a visual acuity of 20/40 or better; however,
patients with an interval of 10 years or more tend to have
a visual acuity that is worse than 20/100. The loss of foveal
light reflex was the earliest sign, followed by the presence
of gray-white flecks in the macular area due to RPE change.
The typical “bull’s-eye” lesion consists of a normal retina in
the central area surrounded by atrophic RPE with depig-
mentation. Atrophic change gradually enlarged to cover the
whole macula and extended to the peripapillary area in the
late disease stage. Sclerotic-appearing choroidal vessels,
attenuation of retinal vessels, and optic atrophy can be
detected. The macula shows a metallic-like sheen underophthalmoscopy at this stage, the so-called “beaten-
bronze” appearance.10,19,22
Fluorescein angiography showed two types of hyper-
fluorescent patterns in the macula, the “bull’s-eye,” and an
oval-shaped hyperfluorescent appearance, representing
diffuse atrophic changes in the macula. Fading of back-
ground choroidal fluorescence, which means “dark
choroid”, in the posterior pole and midperiphery is a char-
acteristic pathologic finding of STGD or fundus flavimacu-
latus. It may be due to acid mucopolysaccharide deposits in
the RPE layer, blocking the effect of emitting and exciting
light.23,24 In one recent study, 62% of patients had this
sign.20 Fourteen of our patients (70%) had this type of
presentation.
Color vision defects are common in STGD, although not
universal.2,21 Color sense discrimination also was affected
as the disease progeessed.11,21 Pinckers25 did not find
a correlation between color vision and visual acuity.
However, our study showed logMAR-converted visual acuity
was significantly associated with total error scores on the
Farnsworth-Munsell 100-Hue Test.
EOG ratios have been reported to be abnormal in
75e80% of patients with STGD.26,27 The result of this test
depends on the extent of RPE involvement and a decreased
Arden ratio may be present in EOG in late-stage STGD. Our
study further demonstrated that logMAR-converted visual
acuity was significantly associated with the Arden ratio.
Scotopic and photopic ERG responses may be normal or
slightly abnormal with reduced Bewave amplitudes in
patients with STGD.3,10,26e28 Our study showed that most
patients had normal or subnormal ERG responses (Table 4).
Dark adaptation tests showed that the final threshold is
usually normal or slightly elevated in STGD. Krill27 reported
that with sufficient preadaptation, dark adaptation is
usually slower but the final thresholds are normal or slightly
elevated. We found normal final thresholds in 70% of our
patients (Table 4).
Visual field testing may be normal or show relative
central scotoma initially, which then progresses to an
absolute scotoma or demonstrates relative or absolute
central or paracentral scotoma in patients with STGD.2,10,22
Peripheral visual field constriction may develop in the
advanced stage of widespread retinal atrophy.2,11,22 Our
study showed central or paracentral scotoma in nine
patients (45%), especially those with poor vision.
Analyzing the macular tomography circularly by OCT, the
fovea was much thinner than the inner and outer rings. This
result may represent an extreme atrophy in this area in
these patients and the OCT finding was compatible with
that seen by ophthalmoscopy. Previous studies showed
significantly thinner fovea on OCT images in patients with
STGD.12,13 The macular thickness of the controls in our
study was compatible with those in two previous studies
on normal macular thickness of normal healthy
individuals.17,18
Visual acuity and color sense discrimination are central
or cone-dependent retinal functions, and the EOG is an
RPE-dependent retinal function test. Previous studies
demonstrated a significant correlation between foveal
thickness and BCVA in patients with STGD.12,13 Our study
also showed a similar result. Moia-Lopes et al29 reported no
significant relation between this disease and color vision
86 J.-P. Sun et al.deficiencies. Our study revealed total error scores on the
Farnsworth-Munsell 100-Hue test were not correlated with
macular thickness.
EOG ratios have been reported to be abnormal in
75e80% of patients with STGD.26,27 Our study further
demonstrated that an Arden ratio as shown by EOG was
correlated with the thickness of the outer ring of the
macula.
Our study demonstrated that logMAR-converted VA was
significantly inversely correlated with foveal thickness on
OCT examination. The Arden ratio of EOG correlated with
the thickness of the outer ring. These results provided
a topographic characterization of visual function impair-
ment in patients with STGD and might provide valuable
information in the diagnosis of STGD.
OCT can both detect and quantify pathological changes
in the eyes of patients with STGD. Since it is currently
available in most clinical settings, OCT may be a good tool
for monitoring and follow-up of STGD. In conclusion, our
data indicated that OCTwas helpful as a visual function test
in diagnosing STGD.Acknowledgments
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